Abbonarsi

Phenotype and molecular characterization of Wilson's disease in Morocco - 18/04/24

Doi : 10.1016/j.clinre.2024.102335 
Nadia Abbassi a, b, , Aicha Bourrahouat c, d, Eduardo Couchonnal Bedoya e, f, Cécile Pagan g, Meriem El Qabli c, Sana Maidoumi a, Abdelouahed Belmalih e, Olivier Guillaud f, Najib Kissani h, Abdelhak Abkari i, Imane Chahid i, Mohammed Abdoh Rafai j, Nezha Mouane k, Yamna Kriouile k, Saadia Aidi l, Moustpha Hida m, Mounia Lakhdar Idrissi m, Mohammed Faouzi Belahsen n, Mohammed El Abkari o, Maria Rkain p, Zahi Ismaili q, Azeddine Sedki a, Muriel Bost e, g, Nisrine Aboussair c, r, Alain Lachaux e, f, s
a Université Cadi Ayyad, Faculté des Sciences Semlalia, LHEAC, 40000, Marrakech, Morocco 
b Université Claude Bernard Lyon 1, INSERM-U1060, INRA, INSA, Laboratoire CarMeN, 69500, Lyon, France 
c Université Cadi Ayyad, Faculté de Médecine et de pharmacie, Laboratoire de recherche de l'enfance, la santé et le développement, 40000, Marrakech, Morocco 
d CHU Mohammed VI de Marrakech, Hôpital Mère-Enfant, Service de Pédiatrie, 40080, Marrakech, Morocco 
e HCL, Centre de référence de la maladie de Wilson, 69500, Lyon, France 
f HCL, Hôpital Mère-Femme-Enfant, Unité de Gastroentrologie, Hépatologie et Nutrition, 69500, Lyon, France 
g HCL, Centre de Biochimie et Biologie Moléculaire, LBMMS, 69500, Lyon, France 
h CHU Mohammed VI de Marrakech, Hôpital Arrazi, Service de Neurologie, 40080, Marrakech, Morocco 
i CHU Ibn Rochd de Casablanca, Hôpital Mère-Enfant, Service de Gastro-Pédiatrie, 20360, Casablanca, Morocco 
j CHU Ibn Rochd de Casablanca, Service de Neurologie adulte, 20360, Casablanca, Morocco 
k CHU Ibn Sina de Rabat, Hôpital Mère-Enfant, Service de Gastro-Pédiatrie, 10100, Rabat, Morocco 
l CHU Ibn Sina de Rabat, Service de Neurologie adulte, 10100 Rabat, Morocco 
m CHU Hassan II de Fès, Hôpital Mère-Enfant, Service de Pédiatrie, 30050 Fès, Morocco 
n CHU Hassan II de Fès, Service de Neurologie adulte, 30050, Fès, Morocco 
o CHU Hassan II de Fès, Service de Gastroenterologie et Hépatologie adulte, 30050 Fès, Morocco 
p CHU Mohammed VI d'Oujda, Hôpital Mère-Enfant, Service de Pédiatrie, 60049 Oujda, Morocco 
q CHU Mohammed VI d'Oujda, Service de Gastroenterologie et Hépatologie adulte, 60049, Oujda, Morocco 
r CHU Mohammed VI de Marrakech, Centre de recherche clinique, Service de Génétique, 40080, Marrakech, Morocco 
s Université Claude Bernard Lyon 1, CIRI-INSERM-U1111, CNRS UMR5308, 69100, Lyon, France 

Corresponding author.

Highlights

The present study is the first population-based epidemiological study on WD in the Maghreb, estimating the prevalence and addressing all aspects of WD: epidemiology, clinical forms, diagnosis, genetic analysis, treatment and mortality rate.
The prevalence of WD was higher in Moroccan population.
The mortality was higher in Moroccan patients with WD and patients died at an early age.
These data can help better understand this disease burden and improve the diagnosis.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background and study aims

In Morocco the prevalence of Wilson disease (WD) and the spectrum of mutations are not known. The aim of the present study was to estimate the prevalence of WD in Morocco, to evaluate the phenotype among a large cohort of WD patients, and to characterize ATP7B variants in a subgroup of WD patients.

Patients and methods

We collected data from 226 patients admitted to five university hospital centers in Morocco between 2008 and 2020. The diagnosis was based on clinical manifestations, function tests and biochemical parameters. The genotype was characterized in 18 families diagnosed at the University Hospital Center of Marrakesh, by next generation sequencing.

Results

The mean annual prevalence in Morocco was 3.88 per 100,000 and the allele frequency was 0.15 %. Among the 226 patients included (121 males and 105 females), 196 were referred for a hepatic or neurological involvement and 30 were asymptomatic. The mean age at diagnosis was 13 ± 5.1 years (range: 5 - 42 years). Consanguinity was found in 63.3 % of patients. The mean duration of illness was 2.8 ± 1.9 years. Kayser-Fleischer rings were found in 131 (67.9 %) of 193 patients. Among the 196 symptomatic patients, 141/159 (88.7 %) had low serum ceruloplasmin (<0.2 g/L) and a high 24-hours urinary copper (>100 μg/day) was found in 173/182 (95.1 %) patients. The initial treatment was D-penicillamine in 207 patients, zinc acetate in five, zinc sulfate in five, and nine patients were not treated; 60/207 (29 %) patients have stopped treatment. A total of 72 patients died; the mortality rate was 31.9 %. Eight different ATP7B variants were identified among the 18 patients studied, of which two were novel (p.Cys1104Arg and p.Gln1277Hisfs*52), and six previously published (p.Gln289Ter, p.Cys305Ter, p.Thr1232Pro, p.Lys1020Arg, p.Glu583ArgfsTer25 and c.51+4A>T). All informative patients were homozygous for the disease-causing mutation.

Conclusion

In Morocco, a high prevalence due to consanguinity and a high mortality rate due to the difficulty of diagnosis and lack of treatment were observed in WD patients. NGS sequencing identified new ATP7B variants in WD patients from Morocco.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Wilson's disease, Prevalence, Phenotype, Genotype, ATP7B gene, Morocco


Mappa


© 2024  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 48 - N° 5

Articolo 102335- Maggio 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Outcomes and factors associated with cryptococcal disease among cirrhotics: A study of the national inpatient sample 2005 to 2014
  • Kishan Patel, Patrick Twohig, Thoetchai Peeraphatdit, Erica J Stohs, Kaeli Samson, Lynette Smith, Jay Patel, Wuttiporn Manatsathit
| Articolo seguente Articolo seguente
  • Automated detection of small bowel lesions based on capsule endoscopy using deep learning algorithm
  • Lan Li, Liping Yang, Bingling Zhang, Guofei Yan, Yaqing Bao, Renke Zhu, Shengjie Li, Huogen Wang, Ming Chen, Chaohui Jin, Yishu Chen, Chaohui Yu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.